PMID: 6982691Nov 1, 1982Paper

Determinants of operative survival following combined mitral valve replacement and coronary revascularization

The Annals of Thoracic Surgery
V J DiSesaS VanDevanter

Abstract

To determine the operative survival rate following combined mitral valve replacement (MVR) and coronary artery bypass graft (CABG) operation, we evaluated 100 patients, who were seen consecutively at the Peter Bent Brigham and Brigham and Women's Hospital from 1972 to 1982. There were 63 men and 37 women; the mean age was 62 years. Thirty-six patients were in New York Heart Association (NYHA) Functional Class III, and 64 were in functional Class IV. Mitral regurgitation was predominant in 76 patients; mitral stenosis, in 24. Emergency operations were performed in 15 patients, and elective or semielective operations were performed in 85. There were 18 operative deaths (18%): 9 in patients having elective operations (10.5%) and 9 in those having emergency operations (60%; p less than 0.01). Significant preoperative factors related to operative death were NYHA functional class, increased pulmonary vascular resistance, lower cardiac index, and lower ejection fraction in the nonsurvivors. The rate of survival did not differ according to sex, age, or degree of coronary artery disease. In addition, myocardial protection with potassium cardioplegia and complete coronary revascularization significantly reduced operative mortality in the...Continue Reading

References

Jul 19, 1979·The New England Journal of Medicine·J W KirklinE H Blackstone
Dec 1, 1978·The Annals of Thoracic Surgery·W C ScottD M Conkle
Jul 1, 1973·Circulation·J J CollinsR Gorlin
Feb 1, 1974·The Annals of Thoracic Surgery·L H Cohn, J J Collins
Jul 1, 1980·The Annals of Thoracic Surgery·L A GoldingD F Phillips

❮ Previous
Next ❯

Citations

Apr 1, 1990·Clinical Cardiology·T T BashourL L Malabed
Oct 13, 2000·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·H FujiiH Imamura
Dec 1, 1990·Journal of the American College of Cardiology·L H CohnJ J Collins
Jul 1, 1999·American Heart Journal·S KhanS Nessim
Oct 4, 2000·The Annals of Thoracic Surgery·R FasolE Joubert-Hubner
Jan 1, 1987·The Annals of Thoracic Surgery·F L JunodJ P McDermott
Jan 1, 1985·Journal of the American College of Cardiology·P H KayA Starr
Jun 1, 1983·Annals of Surgery·A D WhittemoreJ A Mannick
Dec 12, 2012·The Annals of Thoracic Surgery·Thomas SchroeterFarhad Bakthiary
Apr 1, 1990·Journal of Cardiothoracic Anesthesia·K J TumanA D Ivankovich
Jan 1, 1988·American Heart Journal·W M BreisblattH J Berger
Aug 1, 1990·American Heart Journal·T O Cheng
Apr 1, 1986·The American Journal of Cardiology·C J MattinaR A Pizzarello
Jan 1, 1991·Scandinavian Journal of Thoracic and Cardiovascular Surgery·E StåhleH E Hansson
Jul 13, 2011·Journal of Intensive Care Medicine·Ramford Ng, Yerem Yeghiazarians
Sep 1, 1986·Journal of Cardiac Surgery·R M King, J R Pluth
Mar 1, 1989·Journal of Cardiac Surgery·J S RankinJ G Reves
Apr 9, 2010·Yonsei Medical Journal·Sak LeeKyung-Jong Yoo
Jan 1, 1994·Scandinavian Journal of Thoracic and Cardiovascular Surgery·T W DubielE Cadavid
Jul 21, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·R G SeipeltB J Messmer
Jan 1, 1987·Scandinavian Journal of Thoracic and Cardiovascular Surgery·L A Bergdahl, P Iisalo
Jul 26, 2018·Journal of Cardiac Surgery·Ibrahim SultanArman Kilic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.